Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AC Immune (ACIU) Receivables - Other (2016 - 2025)

Historic Receivables - Other for AC Immune (ACIU) over the last 12 years, with Q3 2025 value amounting to $2.0 million.

  • AC Immune's Receivables - Other rose 9716.9% to $2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.0 million, marking a year-over-year increase of 9716.9%. This contributed to the annual value of $1.3 million for FY2024, which is 7972.25% up from last year.
  • AC Immune's Receivables - Other amounted to $2.0 million in Q3 2025, which was up 9716.9% from $2.0 million recorded in Q2 2025.
  • In the past 5 years, AC Immune's Receivables - Other ranged from a high of $464.2 million in Q4 2021 and a low of $288027.1 during Q1 2022
  • Its 5-year average for Receivables - Other is $83.3 million, with a median of $1.3 million in 2024.
  • As far as peak fluctuations go, AC Immune's Receivables - Other skyrocketed by 12744460.01% in 2021, and later tumbled by 9993.13% in 2022.
  • Quarter analysis of 5 years shows AC Immune's Receivables - Other stood at $464.2 million in 2021, then tumbled by 99.91% to $406904.5 in 2022, then skyrocketed by 72.33% to $701214.5 in 2023, then soared by 79.72% to $1.3 million in 2024, then surged by 56.92% to $2.0 million in 2025.
  • Its last three reported values are $2.0 million in Q3 2025, $2.0 million for Q2 2025, and $2.2 million during Q1 2025.